Trial Profile
Safety of switching directly from lamivudine to adefovir, versus overlapping lamivudine and adefovir followed by adefovir monotherapy, in patients with chronic hepatitis B.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Feb 2011
Price :
$35
*
At a glance
- Drugs Adefovir (Primary) ; Lamivudine (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- 10 Feb 2011 New trial record